2026-08-29T09:24:40Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/189962024-09-27T17:18:30Zcom_20.500.12105_2052com_20.500.12105_2051col_20.500.12105_19608

00925njm 22002777a 4500 dc Beauté, Julien author Innocenti, Francesco author Aristodimou, Aristos author Špačková, Michaela author Eves, Caroline author Kerbo, Natalia author Rimhanen-Finne, Ruska author Picardeau, Mathieu author Faber, Mirko author Dougas, Georgios author Halldórsdóttir, Anna Margrét author Jackson, Sarah author Leitēna, Viktorija author Vergison, Anne author Borg, Maria Louise author Pijnacker, Roan author Sadkowska-Todys, Małgorzata author Martins, João Vieira author Rusu, Lavinia Cipriana author Grilc, Eva author Estevez-Reboredo, Rosa Maria author Niskanen, Taina author Westrell, Therese author 2024-02 Background:Leptospirosis is a zoonotic disease caused by bacteria of the genus Leptospira. Humans are infected by exposure to animal urine or urine-contaminated environments. Although disease incidence is lower in Europe compared with tropical regions, there have been reports of an increase in leptospirosis cases since the 2000s in some European countries. Aim: We aimed to describe the epidemiology of reported cases of leptospirosis in the European Union/European Economic Area (EU/EEA) during 2010-2021 and to identify potential changes in epidemiological patterns. Methods: We ran a descriptive analysis of leptospirosis cases reported by EU/EEA countries to the European Centre for Disease Prevention and Control with disease during 2010-2021. We also analysed trends at EU/EEA and national level. Results: During 2010-2021, 23 countries reported 12,180 confirmed leptospirosis cases corresponding to a mean annual notification rate of 0.24 cases per 100,000 population. Five countries (France, Germany, the Netherlands, Portugal and Romania) accounted for 79% of all reported cases. The highest notification rate was observed in Slovenia with 0.82 cases per 100,000 population. Overall, the notification rate increased by 5.0% per year from 2010 to 2021 (95% CI: 1.2-8.8%), although trends differed across countries. Conclusion: The notification rate of leptospirosis at EU/EEA level increased during 2010-2021 despite including the first 2 years of the COVID-19 pandemic and associated changes in population behaviours. Studies at (sub)national level would help broaden the understanding of differences at country-level and specificities in terms of exposure to Leptospira, as well as biases in diagnosis and reporting. Euro Surveill. 2024 Feb;29(7). 10.2807/1560-7917.ES.2024.29.7.2300266 1560-7917 Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 38362624 http://hdl.handle.net/20.500.12105/18996 Epidemiology Europe Leptospirosis Surveillance Epidemiology of reported cases of leptospirosis in the EU/EEA, 2010 to 2021